Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lamia Said Kandil, Ragwa M. Farid, Safaa S. ElGamal & Amira Sayed Hanafy. (2021) Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect. Drug Development and Industrial Pharmacy 47:5, pages 735-740.
Read now
Read now
Walaa Ebrahim Abd El Hady, Osama Abd El-Aazeem Soliman, Hassan Mohamed El Sabbagh & Elham Abdelmonem Mohamed. (2021) Glutaraldehyde-crosslinked chitosan-polyethylene oxide nanofibers as a potential gastroretentive delivery system of nizatidine for augmented gastroprotective activity. Drug Delivery 28:1, pages 1795-1809.
Read now
Read now
Wildan Khairi Muhtadi, Laras Novitasari, Retno Danarti & Ronny Martien. (2020) Development of polymeric nanoparticle gel prepared with the combination of ionic pre-gelation and polyelectrolyte complexation as a novel drug delivery of timolol maleate. Drug Development and Industrial Pharmacy 46:11, pages 1844-1852.
Read now
Read now
Bushra Nabi, Saleha Rehman, Mohammad Fazil, Saba Khan, Sanjula Baboota & Javed Ali. (2020) Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Development and Industrial Pharmacy 46:3, pages 471-483.
Read now
Read now
Walaa Ebrahim Abd El Hady, Elham Abdelmonem Mohamed, Osama Abd El-Aazeem Soliman & Hassan Mohamed EL-Sabbagh. (2019) In vitro–in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. International Journal of Nanomedicine 14, pages 7191-7213.
Read now
Read now
Amira S. Hanafy, Ragwa M. Farid, Maged W. Helmy & Safaa S. ElGamal. (2016) Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management. Drug Delivery 23:8, pages 3111-3122.
Read now
Read now
Articles from other publishers (78)
Jingchen Gao, Xiyuran Wang, Xiangyi Kong, Xujin Yao, Jinyang Ren, Shujun Chen, Na Shen, Zhuo Li, Yitian Wang, Ye Wei, Oleg GlebovFengyuan Che & Qi Wan. (2023) Proline-Loaded Chitosan Nanoparticles Penetrate the Blood–Brain Barrier to Confer Neuroprotection in Mice Cerebral Ischemia Injury. ACS Applied Polymer Materials 5:12, pages 10234-10244.
Crossref
Crossref
Mona Ebrahim Elmoghayer, Noha Mohamed Saleh & Irhan Ibrahim Abu Hashim. (2023) Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Drug Delivery and Translational Research.
Crossref
Crossref
Someshbabu Ramesh Babu, Harshith Hosahalli Shekara, Ashish Kumar Sahoo, Pyda Venkata Harsha Vardhan, Nitheesh Thiruppathi & Madhugiri Prakash Venkatesh. (2023) Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review. Therapeutic Delivery 14:9, pages 571-594.
Crossref
Crossref
Varsha Tiwari, Abhishek Tiwari, Ajay Sharma, Manish Kumar, Deepak Kaushik & Suresh Sagadevan. (2023) An optimistic approach to nanotechnology in Alzheimer's disease management: An overview. Journal of Drug Delivery Science and Technology 86, pages 104722.
Crossref
Crossref
Samar Zuhair Alshawwa, Gihan Salah Labib, Shaimaa M. Badr-Eldin & Abeer Ahmed Kassem. (2023) Solid lipid Lyo-Nanosuspension: A promising stabilized oral delivery system for the antihyperglycemic extract of mistletoe Plicosepalus acacia. Saudi Pharmaceutical Journal 31:8, pages 101689.
Crossref
Crossref
Basant A. Abou-Taleb & Samar O. El-Ganainy. (2023) Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats. Pharmaceutical Research 40:7, pages 1835-1852.
Crossref
Crossref
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Hissana Ather, Shaheen Sultana, Waleed H. Almalki, Pragya Bharti, Ankit Sahoo, Khusbu Dwivedi, Gyas Khan, Shahnaz Sultana, Abdulaziz Alzahrani & Mahfoozur Rahman. (2023) Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art. Biomedicines 11:6, pages 1752.
Crossref
Crossref
Marco T.A. Abbate, Inken K. Ramöller, Akmal H. Sabri, Alejandro J. Paredes, Aaron J. Hutton, Peter E. McKenna, Ke Peng, Jessica A. Hollett, Helen O. McCarthy & Ryan F. Donnelly. (2023) Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND). International Journal of Pharmaceutics 640, pages 123005.
Crossref
Crossref
Estelle-Vionè Louw, Wilna Liebenberg, Clarissa Willers, Admire Dube, Marique E. Aucamp & Minja Gerber. (2022) Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension. Drug Delivery and Translational Research 13:5, pages 1372-1389.
Crossref
Crossref
Yeliz Yıldırım, İskender İnce, Barış Gümüştaş, Özge Vardar, Nil Yakar, Haris Munjaković, Güven Özdemir & Gülnur Emingil. (2023) Development of doxycycline and atorvastatin-loaded chitosan nanoparticles for local delivery in periodontal disease. Journal of Drug Delivery Science and Technology 82, pages 104322.
Crossref
Crossref
Dilyana Georgieva, Denitsa Nikolova, Elena Vassileva & Bistra Kostova. (2023) Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer’s Disease Therapy. Pharmaceutics 15:3, pages 829.
Crossref
Crossref
Rizwan Safdar & Murugesan Thanabalan. (2023) Preparation of Chitosan-Tripolyphosphate Formulated Insulin Microparticles, Their Characterization, ANN Prediction, and Release Kinetics. Journal of Pharmaceutical Innovation.
Crossref
Crossref
Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem A Alanezi, Harshita Abul Barkat, Hazrina Ab Hadi, Ranjit K Harwansh & Vineet Mittal. (2023) Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine 18:2, pages 145-168.
Crossref
Crossref
Jason T. Duskey, Alexander B. Cook, Gabriella Costabile, Giovanni Tosi & Michele Schlich. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
405
434
.
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems
723
759
.
Seung-Hyun Jeong, Ji-Hun Jang & Yong-Bok Lee. (2022) Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. Journal of Pharmaceutical Investigation 53:1, pages 119-152.
Crossref
Crossref
Meltem Ezgi Durgun, Gamze Çamlık, İsmail Tuncer Değim & Yıldız Özsoy. 2023. Nasal Drug Delivery. Nasal Drug Delivery
169
187
.
Prashant Kesharwani, Mahak Fatima, Vanshikha Singh, Afsana Sheikh, Waleed H. Almalki, Virendra Gajbhiye & Amirhossein Sahebkar. (2022) Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis. Biomimetics 7:4, pages 206.
Crossref
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Crossref
Stavroula G. Nanaki, Konstantinos Spyrou, Pelagia Veneti, Niki Karouta, Dimitrios Gournis, Turki N. Baroud, Panagiotis Barmpalexis & Dimitrios N. Bikiaris. (2022) L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine. Polymers 14:19, pages 4004.
Crossref
Crossref
Nicolò Montegiove, Eleonora Calzoni, Carla Emiliani & Alessio Cesaretti. (2022) Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. Journal of Functional Biomaterials 13:3, pages 125.
Crossref
Crossref
Kritika Garg & Pravin Tirgar. (2022) Local Delivery of Metronidazole-loaded N-Trimethyl Quaternary Ammonium
Chitosan Nanoparticles for Periodontitis Treatment. Current Drug Therapy 17:4, pages 233-265.
Crossref
Crossref
Heba A. Gad, Mai Mansour, Haidy Abbas, Rania T. Malatani, Mohamed A. Khattab & Enas Elmowafy. (2022) “Plurol will not miss the boat”: A new manifesto of galantamine conveyance. Journal of Drug Delivery Science and Technology 74, pages 103516.
Crossref
Crossref
Simona Martano, Valeria De Matteis, Mariafrancesca Cascione & Rosaria Rinaldi. (2022) Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration. Nanomaterials 12:14, pages 2337.
Crossref
Crossref
Selma Hamimed, Marwa Jabberi & Abdelwaheb Chatti. (2022) Nanotechnology in drug and gene delivery. Naunyn-Schmiedeberg's Archives of Pharmacology 395:7, pages 769-787.
Crossref
Crossref
Mary B. McGuckin, Jiawen Wang, Rand Ghanma, Nuoya Qin, Santiago D. Palma, Ryan F. Donnelly & Alejandro J. Paredes. (2022) Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. Journal of Controlled Release 345, pages 334-353.
Crossref
Crossref
Samar Zuhair Alshawwa, Abeer Ahmed Kassem, Ragwa Mohamed Farid, Shaimaa Khamis Mostafa & Gihan Salah Labib. (2022) Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics 14:4, pages 883.
Crossref
Crossref
Nikita Subhash Hinge, Himanshu Kathuria & Murali Monohar Pandey. (2022) Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 26, pages 101303.
Crossref
Crossref
Francisca Espinoza, Walther Ide, Natalia Saldivia & Diego Zelada. 2022. Polymeric Biomaterials for Healthcare Applications. Polymeric Biomaterials for Healthcare Applications
369
402
.
Sutapa Som Chaudhury, Koel Sinha & Chitrangada Das Mukhopadhyay. (2021) Intranasal route: The green corridor for Alzheimer's disease therapeutics. Journal of Drug Delivery Science and Technology 66, pages 102791.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Mohamed A. Alfaleh, Obaid Afzal, Abdulmalik S. A. Altamimi, Ashif Iqubal & Rasheed A. Shaik. (2021) Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches. Journal of Personalized Medicine 11:11, pages 1116.
Crossref
Crossref
Noha S. El-Salamouni & Amira Sayed Hanafy. (2021) Hyaluronic-benzydamine oromucosal films outperform conventional mouth rinse in ulcer healing. Journal of Drug Delivery Science and Technology 65, pages 102690.
Crossref
Crossref
Mahmoud Agami, Rasha A. Shaalan, Saied F. Belal & Marwa A.A. Ragab. (2021) LC-MS bioanalysis of targeted nasal galantamine bound chitosan nanoparticles in rats’ brain homogenate and plasma. Analytical and Bioanalytical Chemistry 413:20, pages 5181-5191.
Crossref
Crossref
Samar O El-Ganainy, Mennatallah A Gowayed, Mahmoud Agami, Passant Mohamed, Marwa Belal, Ragwa M Farid & Amira S Hanafy. (2021) Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics. Nanomedicine 16:15, pages 1281-1296.
Crossref
Crossref
R. Majumder, T. Pal, A. Basumallick & Chitrangada Das Mukhopadhyay. (2021) Functionalized carbon nano onion as a novel drug delivery system for brain targeting. Journal of Drug Delivery Science and Technology 63, pages 102414.
Crossref
Crossref
Yilan Xu, Manna Zhao, Dongming Zhou, Tingting Zheng & Heng Zhang. (2021) The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy. Biomedicine & Pharmacotherapy 137, pages 111360.
Crossref
Crossref
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi, Ujala Zafar, Muhammad Mahtab Aslam Khan Khakwani, Saadullah Khattak, Yuan-Kun Zhai, En-She Jiang, Meng Zheng, Shao-Feng Duan, Jian-She Wei, Dong-Dong Wu & Xin-Ying Ji. (2021) Nanomedicine: A Promising Way to Manage Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Crossref
Namdev Dhas, Tejal Mehta, Shilpa Sharma, Atul Garkal, Dattatray Yadav, Kartik Hariharan, Babeeta Shamjetshabam, Shubham Khot, Ritu Kudarha, Priyanka Bangar, Gajanan Arbade & Pratap Kalyankar. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
351
387
.
Ganesh B. Shevalkar, Mahendra K. Prajapati, Rohan V. Pai & Kamlesh D. Mali. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
249
266
.
Shiv Bahadur & Kamla Pathak. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
187
207
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Zachary Warnken, Yang Lu, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
209
233
.
Rajesh Kumar, Monica Gulati, Sachin Kumar Singh, Deepika Sharma & Omji Porwal. (2020) Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps. CNS & Neurological Disorders - Drug Targets 19:9, pages 663-675.
Crossref
Crossref
Anupam Sarma & Malay K. Das. (2020) Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Molecular Biomedicine 1:1.
Crossref
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Sidra Bashir, Nadiah Zafar, Noureddine Lebaz, Asif Mahmood & Abdelhamid Elaissari. (2020) Hydroxypropyl Methylcellulose-Based Hydrogel Copolymeric for Controlled Delivery of Galantamine Hydrobromide in Dementia. Processes 8:11, pages 1350.
Crossref
Crossref
Eniko Manek, Ferenc Darvas & Georg A. Petroianu. (2020) Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer’s Disease. Molecules 25:20, pages 4866.
Crossref
Crossref
Barnabas Wilson & Kannoth Mukundan Geetha. (2020) Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease. Journal of Controlled Release 325, pages 25-37.
Crossref
Crossref
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Crossref
Gülcem Altinoglu & Terin Adali. (2020) Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems. Current Drug Targets 21:7, pages 628-646.
Crossref
Crossref
Bapi Gorain, Davinaa C. Rajeswary, Manisha Pandey, Prashant Kesharwani, Santosh A. Kumbhar & Hira Choudhury. (2020) Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. Current Pharmaceutical Design 26:19, pages 2233-2246.
Crossref
Crossref
Elena S. López, Ana L.L. Machado, Lorena B. Vidal, Roberto González-Pizarro, Amelia D. Silva & Eliana B. Souto. (2020) Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges. Current Pharmaceutical Design 26:12, pages 1235-1250.
Crossref
Crossref
Dilyana Georgieva, Krasimira Ivanova-Mileva, Sijka Ivanova, Bistra Kostova, Dimitar Rachev & Darinka Christova. (2020) Thermoresponsive poly(N-isopropylacrylamide) copolymer networks for galantamine hydrobromide delivery. Colloid and Polymer Science 298:4-5, pages 377-384.
Crossref
Crossref
Neel R. Solanki, Deepa H. Patel & Dipali R. Talele. (2020) Dextran Microparticulate Inhalable Dry Powder for the Treatment of Cystic Fibrosis and Mucopolysaccharidosis. Current Drug Delivery 17:3, pages 218-228.
Crossref
Crossref
Ramin Ansari, Seyed Mahdi Sadati, Negin Mozafari, Hajar Ashrafi & Amir Azadi. (2020) Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders. European Polymer Journal 128, pages 109607.
Crossref
Crossref
Joana Bicker, Ana Fortuna, Gilberto Alves & Amílcar Falcão. (2020) Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders. Current Pharmaceutical Design 26:5, pages 594-619.
Crossref
Crossref
Stavroula G. Nanaki, Konstantinos Spyrou, Chryssa Bekiari, Pelagia Veneti, Turki N. Baroud, Niki Karouta, Ioannis Grivas, Georgios C. Papadopoulos, Dimitrios Gournis & Dimitrios N. Bikiaris. (2020) Hierarchical Porous Carbon—PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer’s Disease Therapy. Pharmaceutics 12:3, pages 227.
Crossref
Crossref
Wenyuan Chen, Ruiteng Li, Siqing Zhu, Jinqiu Ma, Lulu Pang, Baiping Ma, Lina Du & Yiguang Jin. (2020) Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer’s disease induced by lipopolysaccharides. International Journal of Pharmaceutics 578, pages 119115.
Crossref
Crossref
Shweta Sharma. 2020. Sustainable Agriculture Reviews 43. Sustainable Agriculture Reviews 43
131
159
.
Keith Morris-Schaffer, Alyssa K. Merrill, Candace Wong, Katrina Jew, Marissa Sobolewski & Deborah A. Cory-Slechta. (2019) Limited developmental neurotoxicity from neonatal inhalation exposure to diesel exhaust particles in C57BL/6 mice. Particle and Fibre Toxicology 16:1.
Crossref
Crossref
Farhatun Najat Maluin, Mohd Zobir Hussein, Nor Azah Yusof, Sharida Fakurazi, Idris Abu Seman, Nur Hailini Zainol Hilmi & Leona Daniela Jeffery Daim. (2019)
Enhanced fungicidal efficacy on
Ganoderma boninense
by simultaneous co-delivery of hexaconazole and dazomet from their chitosan nanoparticles
. RSC Advances 9:46, pages 27083-27095.
Crossref
Crossref
Farhatun Najat Maluin, Mohd Zobir Hussein, Nor Azah Yusof, Sharida Fakurazi, Abu Seman Idris, Nur Hailini Zainol Hilmi & Leona Daniela Jeffery Daim. (2019) Preparation of Chitosan–Hexaconazole Nanoparticles as Fungicide Nanodelivery System for Combating Ganoderma Disease in Oil Palm. Molecules 24:13, pages 2498.
Crossref
Crossref
Jyoti Gupta, Munazza Tamkeen Fatima, Zeyaul Islam, Rizwan Hasan Khan, Vladimir N. Uversky & Parveen Salahuddin. (2019) Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease. International Journal of Biological Macromolecules 130, pages 515-526.
Crossref
Crossref
Wilson Barnabas. (2019) Drug targeting strategies into the brain for treating neurological diseases. Journal of Neuroscience Methods 311, pages 133-146.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Xinxin Wang & Fangxia Guan. 2019. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
117
133
.
Cristina de la Torre & Valentín Ceña. (2018) The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics. Pharmaceutics 10:4, pages 190.
Crossref
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Mahavir Bhupal Chougule, Sunday A. Shoyele & Amit Alexander. (2018) Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. Journal of Controlled Release 281, pages 139-177.
Crossref
Crossref
Vassilis Bourganis, Olga Kammona, Aleck Alexopoulos & Costas Kiparissides. (2018) Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. European Journal of Pharmaceutics and Biopharmaceutics 128, pages 337-362.
Crossref
Crossref
Eleni Samaridou & Maria José Alonso. (2018) Nose-to-brain peptide delivery – The potential of nanotechnology. Bioorganic & Medicinal Chemistry 26:10, pages 2888-2905.
Crossref
Crossref
Yunhai Feng, Haisheng He, Fengqian Li, Yi Lu, Jianping Qi & Wei Wu. (2018) An update on the role of nanovehicles in nose-to-brain drug delivery. Drug Discovery Today 23:5, pages 1079-1088.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
Sheng-Tien Li, Tai-Horng Young, Chih-Feng Lin & Tsung-Wei Huang. (2017) Promotion of Olfactory Receptor Neuron Differentiation of Olfactory Neuroepithelial Cells by Using Chitosan Solution. American Journal of Rhinology & Allergy 31:5, pages 289-292.
Crossref
Crossref
Athika Darumas Putri, Bayu Tri Murti, Myalowenkosi Sabela, Suvardhan Kanchi & Krishna Bisetty. 2017. Chitosan. Chitosan
311
359
.
Ming Ming Wen, Noha S. El-Salamouni, Wessam M. El-Refaie, Heba A. Hazzah, Mai M. Ali, Giovanni Tosi, Ragwa M. Farid, Maria J. Blanco-Prieto, Nashiru Billa & Amira S. Hanafy. (2017) Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release 245, pages 95-107.
Crossref
Crossref
Qizhi Zhang & Chi Zhang. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors
227
239
.
Jingchen Gao, Xiyuran Wang, Xiangyi Kong, Hui Wang, Xujin Yao, Jinyang Ren, Jiangdong Sun, Yitian Wang, Ye Wei, Tao Lin, Fengyuan Che & Qi Wan. (2022) Proline-Loaded Chitosan Nanoparticles Penetrate the Blood-Brain Barrier to Confer Neuroprotection in Mice Cerebral Ischemia Injury. SSRN Electronic Journal.
Crossref
Crossref